• Fund Type: ETF
  • Objective: Health Care
  • Asset Class: Equity
  • Geographic Focus: U.S.

First Trust NYSE Arca Biotechnology Index Fund

+ Add to Watchlist

FBT:US

96.2200 USD 1.2000 1.26%

As of 20:04:03 ET on 10/24/2014.

Snapshot for First Trust NYSE Arca Biotechnology Index Fund (FBT)

Open: 95.1400 High - Low: 96.5491 - 94.7310 Primary Exchange: NYSE Arca
Volume: 228,588 52-Week Range: 60.7800 - 96.5491 Beta vs BTK: 1.0005

ETF Chart for FBT

No chart data available.
  • FBT:US 96.2200
  • 1D
  • 1M
  • 1Y
95.0200
Interactive FBT Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for FBT

First Trust NYSE Arca Biotechnology Index Fund is an exchange-traded fund incorporated in the USA. The Fund seeks investment results that correspond to the price and yield of an equity index called the Amex Biotechnology Index.

Inception Date: 2006-06-23 Telephone: 1-630-765-8000
Managers: -
Web Site: www.ftportfolios.com

Fundamentals for FBT

NAV (on 2014-10-24) 96.1779
Assets (M) (on 2014-10-24) 1,697.5390
Shares out (M) 17.65
Market Cap (M) 1,698.28
% Premium 0.04
Average 52-Week % Premium 0.0177
Fund Leveraged N

Dividends for FBT

Dividend Type Discontinued
Dividend Frequency Irreg
Last Dividend Net -
Dividend Yield (ttm) -%

Performance for FBT

1-Month +2.65% 1-Year +46.99%
3-Month +17.44% 3-Year +39.25%
Year To Date +39.09% 5-Year +29.29%
Expense Ratio 0.60

Top Fund Holdings for FBT

Filing Date: 10/23/2014
Name Position Value % of Total
Celgene Corp 595,437 59,781,875 3.575%
Alexion Pharmaceuticals Inc 318,483 59,212,359 3.541%
Illumina Inc 318,494 59,188,925 3.540%
NPS Pharmaceuticals Inc 2,005,275 58,313,397 3.488%
Amgen Inc 392,841 57,845,837 3.460%
Cubist Pharmaceuticals Inc 796,607 57,690,279 3.450%
Incyte Corp 1,048,003 57,587,765 3.444%
Myriad Genetics Inc 1,498,484 56,942,392 3.406%
Pharmacyclics Inc 467,899 56,765,507 3.395%
Nektar Therapeutics 4,232,226 56,076,995 3.354%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil